Pharmacokinetics of tenofovir during pregnancy and postpartum. - Wikidata - wikimedia - TriplyDB

Pharmacokinetics of tenofovir during pregnancy and postpartum.

Pharmacokinetics of tenofovir during pregnancy and postpartum.

http://www.wikidata.org/entity/Q36888597

about

Pregnancy-Associated Changes in Pharmacokinetics: A Systematic Review Antiretroviral Treatment in HIV-1-Positive Mothers: Neurological Implications in Virus-Free Children Safety of oral tenofovir disoproxil fumarate-based HIV pre-exposure prophylaxis use in lactating HIV-uninfected women.Toward a universal antiretroviral regimen: special considerations of pregnancy and breast feeding.Gestation-Specific Changes in the Anatomy and Physiology of Healthy Pregnant Women: An Extended Repository of Model Parameters for Physiologically Based Pharmacokinetic Modeling in Pregnancy.Pharmacokinetics and Placental Transfer of Elvitegravir, Dolutegravir, and Other Antiretrovirals during Pregnancy.Therapeutic drug monitoring of antiretroviral drugs in HIV-infected patients.Levels of bone markers in a population of infants exposed in utero and during breastfeeding to tenofovir within an Option B+ programme in Malawi.Dolutegravir pharmacokinetics in pregnant and postpartum women living with HIV.Molecular Mechanisms for Species Differences in Organic Anion Transporter 1, OAT1: Implications for Renal Drug Toxicity Tenofovir and tenofovir-diphosphate concentrations during pregnancy among HIV-uninfected women using oral preexposure prophylaxis

P2860

Q28109657-B6E8C069-EB5E-46BF-9493-7992E50B53AE Q37691000-895DD343-B311-466B-875E-02C052A1BB62 Q38750453-2F444461-7DAE-44FB-BF36-FAE2F89E1530 Q38828635-078E24DE-17B6-4A91-8A4F-606977479F02 Q38841163-5F17D02A-2DBD-4573-96FA-2204BC9CA5C6 Q38872808-1AE99B33-519D-43B3-B0E0-F6CBEE8BF1C0 Q38954109-9DB799BD-BD8C-4FCC-9C87-76498726AB05 Q39520236-3C8A61F7-8EF7-4A11-B10E-6382EDFF3F35 Q47548999-98CD1020-A140-4617-9DAF-6F745BE32A53 Q56889854-F411139F-22C9-48CC-BF27-678EF7DEFAD3 Q56910156-C7E0FBEA-8170-4DE4-9481-E55629FB09F1

P2860

Pharmacokinetics of tenofovir during pregnancy and postpartum.

http://www.wikidata.org/entity/Q36888597

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Pharmacokinetics of tenofovir during pregnancy and postpartum.

@en

type

label

Pharmacokinetics of tenofovir during pregnancy and postpartum.

@en

prefLabel

Pharmacokinetics of tenofovir during pregnancy and postpartum.

@en

P1433

Q36888597-E9044379-F8A5-4C0E-A305-EC09EF84E580

P1476

Q36888597-59E77813-B482-4B92-9C92-06FE6DF51275

P2093

Q36888597-09856176-2A97-4A75-84E6-5CD15CF55279

Q36888597-10592185-C055-41CB-8DE5-CF12472095EC

Q36888597-1283B2CB-1EBC-48BE-AB47-71B19907CA5E

Q36888597-1A8E3D4E-FD60-4318-9E88-D036681F0871

Q36888597-1BBC78A3-373F-4408-9F7F-4ACF60AD632F

Q36888597-22B449FD-0B71-44ED-8CE3-BF61C9701556

Q36888597-2DBEAB09-B6C6-49F9-B545-07A93932DCE6

Q36888597-4404027D-05E9-4D82-A312-20C23E4492A0

Q36888597-8387CFC9-9D96-4411-83D1-7817DA8FB46A

Q36888597-87265A7A-08DB-4E0C-BD22-610B569B794B

P2860

Q36888597-041E4FDB-21A9-44C2-9204-E6531C180A97

Q36888597-3E4BFBDC-052F-46FB-A6FE-1D57E1E18AB2

Q36888597-42CFE537-9A5A-4066-9C61-E52C3B74853E

Q36888597-432FA62D-4696-4155-8247-2314D30BD1CF

Q36888597-4BE1488C-B679-43B0-A527-1F260F3F566B

Q36888597-5EAF59E0-3474-47DA-9E82-61DB9F54E2EA

Q36888597-8A9153A5-26BD-4B83-9D25-0A4540638398

Q36888597-8ED0B84D-E3A7-421E-9E42-83261561F5A9

Q36888597-956F9A67-DF2F-467F-BE87-2B4D7172590C

Q36888597-BB2EAFE5-ABDA-49ED-A532-226BCCFA214E

P304

Q36888597-EC0C431D-2297-4B23-9DB6-F3A134332637

P31

Q36888597-E6ED7C24-0D82-4EAA-9919-6EBFC9F422F4

P356

Q36888597-A5430380-70E8-45F2-92D2-29762A2164AC

P433

Q36888597-AAE2E284-99FB-4F7F-B4F0-D67920FA14B4

P478

Q36888597-3FA639EB-AB63-4BC9-B7C1-37473A137A13

P577

Q36888597-62072067-4807-43E5-8C07-76709F0643A8

P698

Q36888597-FA10BB60-9B46-4CC4-BB5D-019987505942

P921

Q36888597-B4AD07B3-8586-4CE2-AC22-957BD66F2B3A

P932

Q36888597-75923541-9125-4DAB-A10E-0A84FCBDAD56

P356

P1433

P1476

Pharmacokinetics of tenofovir during pregnancy and postpartum.

@en

P2093

A Stek

http://www.w3.org/2001/XMLSchema#string

B M Best

http://www.w3.org/2001/XMLSchema#string

C Hu

http://www.w3.org/2001/XMLSchema#string

C V Fletcher

http://www.w3.org/2001/XMLSchema#string

D H Watts

http://www.w3.org/2001/XMLSchema#string

E Hawkins

http://www.w3.org/2001/XMLSchema#string

E Smith

http://www.w3.org/2001/XMLSchema#string

E V Capparelli

http://www.w3.org/2001/XMLSchema#string

H Li

http://www.w3.org/2001/XMLSchema#string

International Maternal Pediatr ...... l Trials (IMPAACT) P1026s Team

http://www.w3.org/2001/XMLSchema#string

P2860

Comparison of bone and renal effects in HIV-infected adults switching to abacavir or tenofovir based therapy in a randomized trial

Impact of a tenofovir disoproxil fumarate plus ritonavir-boosted protease inhibitor-based regimen on renal function in HIV-infected individuals: a prospective, multicenter study.

Plasma and intracellular tenofovir pharmacokinetics in the neonate (ANRS 12109 trial, step 2)

U.S. Public Health Service Task Force recommendations for use of antiretroviral drugs in pregnant HIV-1-infected women for maternal health and interventions to reduce perinatal HIV-1 transmission in the United States.

Pharmacokinetics and safety of single-dose tenofovir disoproxil fumarate and emtricitabine in HIV-1-infected pregnant women and their infants

Pregnancy-related effects on tenofovir pharmacokinetics: a population study with 186 women.

The simultaneous assay of tenofovir and emtricitabine in plasma using LC/MS/MS and isotopically labeled internal standards.

Pharmacokinetic optimization of antiretroviral therapy in pregnancy.

The pharmacokinetics, safety and efficacy of tenofovir and emtricitabine in HIV-1-infected pregnant women.

Pharmacokinetics of didanosine in antepartum and postpartum human immunodeficiency virus--infected pregnant women and their neonates: an AIDS clinical trials group study.

P304

502-511

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/HIV.12252

http://www.w3.org/2001/XMLSchema#string

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

16

http://www.w3.org/2001/XMLSchema#string

P577

2015-05-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25959631

http://www.w3.org/2001/XMLSchema#string

P921

postpartum period

P932

4862736

http://www.w3.org/2001/XMLSchema#string